- Joined
- Oct 22, 2017
- Messages
- 21,095
- Reaction score
- 6,288
- Gender
- Male
- Political Leaning
- Conservative
The NIH has the funding, but they're not funding clinical trials for hydroxychloroquine or chloroquine...and this is why...
"...Researchers credit the advanced stages of the remdesivir and sarimulab trials to the fact that pharmaceutical companies have exclusive rights to these drugs and have an incentive to get studies moving.
Hydroxychloroquine, on the other hand, is an inexpensive generic drug made by several companies, so no one company stands to make much money off it.
"There are financial drivers in this system," said Dr. Kevin Tracey, president of the Feinstein Institutes for Medical Research at Northwell. "I think that's just the reality, frankly." ..."
I guess you didn't read the article after all.
That's a reason that drug companies may not want to experiment, but many others do have incentive, and are launching studies. Seriously, given how quickly the virus has developed, are you surprised that funding grants, often established years in advance, aren't in place?
And FYI - that's another tangent, and attempt at deflection. But you keep trying.